NOMAS includes 3289 participants followed prospectively to determine stroke incidence, risk factors, and prognosis. The study is approved by the Institutional Review Boards of Columbia University and the University of Miami, and participants provided written informed consent. Details of the study have been published previously. [3] [4] [5] [6] From the entire NOMAS cohort, we excluded 378 participants with history of meningitis, head trauma, or radiation to rule out secondary headache.
M
igraine with aura has been associated with a slightly elevated stroke risk. 1 However, the association between migraine and subclinical cerebrovascular disease is limited to a few predominantly white population studies. 2 In the Northern Manhattan Study (NOMAS) and a racially/ethnically diverse population-based urban cohort, we hypothesized that migraine is associated with white matter hyperintensity volume (WMHV) and silent brain infarction (SBI).
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including covariates that were associated with migraine in the full NOMAS cohort at P<0.10, those that were associated with WMHV or SBI in multivariable-adjusted regression models at P<0.10, and the time span from baseline interview to the time of MRI. Migraine was examined as a dichotomous variable. In secondary exploratory analyses, migraine with and without aura was analyzed separately versus no migraine. We examined possible interactions of migraine with sex and race/ethnicity in relation to the outcomes, but we did not observe the effect modification at P<0.10, so stratified analyses were not conducted. Table 1 shows the distribution of the demographic and vascular risk factors in the study population across migraine categories. Covariates included in the fully adjusted models were age, sex, race/ethnicity, insurance status, high school completion, smoking, mild-to-moderate alcohol use, diabetes mellitus, hypertension, and body mass index. Among those with MRI data, the frequency of migraine was 19% (n=546), 6% with aura, 13% without aura. The prevalence of self-reported migraine was 17%.
Results
Years between baseline and MRI ranged from 2 to 11 (mean±SD, 5.7±1.5; median, 5.4). Fifty-six participants (10%) had SBI, of whom 15 also had migraines and only 2 had aura (which prevented further analysis of the effects of migraine with aura separately). The mean (±SD) WMHV was 0.65 (±0.84; interquartile range, 0.20%-0.71%; median, 0.34 total cranial volume). Table 2 shows the relationship between migraine overall and the 2 outcomes. Migraine overall was associated with >2-fold greater odds of SBI after adjusting for covariates. The association between migraine without aura and SBI was even stronger (model 2; odds ratio, 2.6; 95% confidence interval, 1.3-5.5). The Figure shows the percentage of participants with an SBI stratified by migraine status and age categories. Infarcts were found most commonly in the white matter (13%), cerebellum (10%), and frontal cortex (7%). There was no association between migraine status and WMHV in either unadjusted or fully adjusted models.
Discussion
We found that participants with a self-reported history of migraine were more likely to have SBI, whereas there was no association between migraine and white matter lesion load. The association between migraine and SBI was independent of cardiovascular risk factors and was significant in the subgroup with migraine without aura. Migraine seems to be an important stroke risk factor for younger individuals 11 ; however, we have shown that migraine may also be an important risk factor even for much older populations (Table 2) . We did not find race/ethnic differences in the odds of SBI by migraine diagnosis. Unexpectedly, we found no associations between WMHV and migraine or its subgroups. Perhaps the group difference in WMH was not detected because of the high burden of other cardiovascular risk factors in our racially diverse older cohort.
The strengths of this study include the large stroke-free population-based race/ethnically diverse older cohort that includes a large proportion of Hispanic participants, who are typically under-represented in studies of migraine. However, because of the cross-sectional design, we are unable to infer a causal or temporal association between migraine and SBI. Migraine was identified by self-report although the details of the history of headache allowed classification as migraine without selection bias. The questionnaire was not systematically validated; however, the questions were based on the International Classification of Headache Disorders-2 criteria. 8 Our definition of visual auras confined to visual changes, such as spots, stars, lines, and flashing lights, is a restrictive one. However, we do not think that this was a significant problem because the prevalence of migraine aura in our sample size was representative when historically compared, 11, 12 and nonvisual migraine symptoms are much less common.
Although the risk of ischemic stroke in people with migraine is considered small, the potential for more aggressive measures of risk factor reduction in individuals with migraine found to have SBI and other vascular risk factors needs consideration. Larger prospective multiethnic studies are necessary to elucidate the potential for SBI accumulation as a biomarker for subclinical cerebrovascular disease in individuals with migraine.
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